CytomX Therapeutics
CTMX
#7478
Rank
NZ$0.92 B
Marketcap
NZ$4.23
Share price
-0.62%
Change (1 day)
-29.00%
Change (1 year)

Market capitalization of CytomX Therapeutics (CTMX)

Market cap: NZ$0.92 Billion

As of October 2026 CytomX Therapeutics has a market cap of NZ$0.92 Billion. This makes CytomX Therapeutics the world's 7478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytomX Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.92 B-28.28%
2025NZ$1.28 B765%
2024NZ$0.14 B-9.57%
2023NZ$0.16 B-1.41%
2022NZ$0.16 B-59.74%
2021NZ$0.41 B-5.57%
2020NZ$0.43 B-22.02%
2019NZ$0.56 B-44.65%
2018NZ$1.01 B-11.1%
2017NZ$1.14 B97.67%
2016NZ$0.57 B-47.44%
2015NZ$1.09 B

End of Day market cap according to different sources

On Oct 15th, 2026 the market cap of CytomX Therapeutics was reported to be:

NZ$0.92 Billion
by Nasdaq info icon info icon
NZ$0.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.26 B 146.19%๐Ÿ‡บ๐Ÿ‡ธ USA